Aissatou ToureAissatou Toure is a pharmacist biologist specialised in Immunology and a researcher at the Pasteur Institute in Dakar where she heads the Unit of Immunology and conducts research in the area of immunology of malaria.
She is a member of the scientific advisory group of the European Vaccine Initiative (EVI) and of the expert group of WHO on malaria vaccines (MALVAC).
In parallel to her scientific activities as researcher in malaria, Dr Toure has different activities in the field of ethics which represents for her a major area of interest.
Dr Toure is a member of the Senegalese National Ethic Committee for Health Research since 2003, tasked with evaluating scientific and ethical aspects of projects in health research, advising health authorities in the area of ethics, and training health research in ethics.
Since 2012 Dr Toure is a member of the Working Group WG on the Revision of CIOMS 2002 International Ethical Guidelines for Biomedical Research Involving Human Subjects.
From 2006 to 2013 Dr Toure was a member of the UNESCO International Committee on Bioethics and as such participated to reports on various bioethics topics.
From 2003 to 2007, she has been a member of the African Committee (Developing Countries Coordinating Committee or DCCC) of the European program EDCTP (European and Developing Countries Clinical Trials Partnership) serving as focal point for the activities in the field of ethics that included building capacity, strengthening of national ethics committees, etc.
She has been also a member of the Project Advisory Group (since 2004) that advises WHO on the Meningitis Vaccine Project (MVP) on different aspects of the projects including ethical aspects.
Aissatou Toure has also participated in different activities of capacity building in ethics at the national level as well at the international level: participation to the writing of  WHO manual on basic concepts for capacity building of health research committee, facilitators in training workshops, organization of international conferences (Bioethics Days for Central and West Africa).

pdfClick here for the signed Code of Conduct and Declaration of Interests forms

New Meetings

1st Working Group on DILI Meeting, Geneva, Switzerland, 27-28 April 2017

11th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 22-23 March 2017

CIOMS 84th Executive Committee Meeting, Geneva, Switzerland, 28 November 2017

 

Recent Meetings

83rd CIOMS Executive Committee/General Assembly Meeting, Geneva, Switzerland, 29 November 2016

10th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 6-7 September 2016

10th Working Group Meeting on Revision of CIOMS International Ethical Guidelines, Utrecht, Netherlands, 1-3 June 2016

8th CIOMS Working Group Meeting on Vaccine Safety, Accra, Ghana, 22-23 March 2016

9th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 15-16 March 2016

82nd CIOMS Executive Committee Meeting, Geneva, Switzerland, 8 December 2015

ISoP meeting, Prague, Czech Republic, 27-30 October 2015

8th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 24-25 September 2015

7th CIOMS Working Group meeting on Vaccine Safety, near Philadelphia, PA, USA, 21-22 September 2015

8th Working Group X on Meta-analysis, New Brunswick, NJ, USA, 1-2 July 2015

9th Working Group on Revision of CIOMS International Ethical Guidelines, Paris, France, 14-16 June 2015

th Working Group on MedDRA IWG, Chavannes-de-Bogis, Switzerland, 19-20 May 2015

8th Working Group on Revision of CIOMS International Ethical Guidelines, Vilnius, Lithuania, 22-24 March 2015

6th Vaccine Safety Working Group, Lyon, France, 18-19 March 2015 

ISoP Meeting, Mysore, India, 12-14 January 2015

 

WHO on Twitter

WHO Q: Is it ethically correct to offer a test for drug resistant TB when the treatment is not available? A: Yes… https://t.co/uf7S379RTA
18mreplyretweetfavorite
WHO RT @UNICEF: Tuberculosis is not a disease of the past! #WorldTBDay #endTB @WHO https://t.co/uUvWJWC5VD
46mreplyretweetfavorite
WHO Q: Do governments have an ethical obligation to provide tuberculosis care for free? A: Yes https://t.co/qLJsFUzi1fhttps://t.co/xYVpg959P5
49mreplyretweetfavorite
WHO More than a third (4.3 million) of people with #TB go undiagnosed or unreported, some receive no care at all… https://t.co/wrPDfIW6UP
1hreplyretweetfavorite
WHO RT @WHOJordan: يمثل اليوم العالمي للسل فرصة لإذكاء الوعي بعبء السل في جميع أنحاء العالم والجهود المبذولة في مجال الوقاية منه ورعاية المصابي…
1hreplyretweetfavorite

Visitors

1397412

Member Login

Member Login